Periodic Reporting for period 2 - I-GENE (In-vivo Gene Editing by NanotransducErs)

CRISPR/Cas9 and enzyme-based editors hold promise for genome surgery by erasing harmful mutations while re-writing them in helpful ones, but face critical barriers related to safety. Here, we propose a new concept of genome engineering based on nanotranducers. Nanotransducers...